Tetrahydrogen isotope derivatives as anti doomsday inhibitors of Bcl-2 and pharmaceutical compounds containing this substance

摘要

The invention refers to the first equation compound of Bcl-2 as a selective protein inhibitor, which may help to manufacture drugs for treating cancer, autoimmune diseases and immune system diseases: the first equation space, wherein RA, Rb, RC, RD, t, R3, R4, R5, X and, Het is defined in the description